1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

Pfizer Inc. (NYSE: PFE) Share Price and News

$26.03 $0.33 (1.3%) 6 December 2025 at 8:00:00 am AEDT

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 06-12-2025, 08:00:00am AEDT
Current Price $26.03
Change $0.33 (1.3%)
Close Price $26.03
Open Price $25.77
Bid $25.96
Ask $25.99
Day Range $25.64 - $26.12
Year Range $20.92 - $27.69
Volume 47,443,701
Average Volume 68,054,719
Market Cap $147,999,031,300.00
Earnings Per Share $1.72

    • Pfizer Inc. (NYSE: PFE)
    Latest News

    A hand holding a pin about to burst a balloon, indicating a crash or drop in asx shares
    Share Market News

    Will Pfizer's COVID-19 vaccine end the ASX tech share rally?

    | Bernd Struben

    With Pfizer's announcement of a promising COVID-19 vaccine, ASX tech shares are largely missing out on the global share market…

    Read more »

    vaccine
    Share Market News

    ASX 200 to surge higher after Pfizer COVID-19 vaccine success

    | James Mickleboro

    It looks set to be a fantastic day for the S&P/ASX 200 Index (ASX:XJO) on Tuesday after strong results from Pfizer's COVID-19…

    Read more »

    virus image
    International Stock News

    Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada

    | Eric Volkman

    Health Canada will determine BNT162b2's suitability for approval as clinical trial data comes in.

    Read more »

    person receiving coronavirus vaccine injection into the arm
    International Stock News

    3 reasons Pfizer and BioNTech will have coronavirus vaccine data before Moderna

    | Brian Orelli, PhD

    Different clinical trial designs gives the duo an advantage, but coming in first isn't the end goal for vaccine makers.

    Read more »

    doctor giving little boy vaccine injection in his arm
    International Stock News

    Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

    | Brian Orelli, PhD

    The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

    Read more »

    gloved hand injecting coronavirus vaccine into person's arm
    International Stock News

    Coronavirus vaccine trial adverse event was probably unrelated to treatment

    | Brian Orelli, PhD

    The paused clinical trial has already resumed.

    Read more »

    vaccine shot
    International Stock News

    Pfizer says it could know if its COVID-19 vaccine candidate works in October

    | Todd Campbell

    The drugmaker's CEO said there was a more than 60% chance that they would know by the end of next…

    Read more »

    doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
    International Stock News

    The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

    | Keith Speights

    Hint: It's not Moderna.

    Read more »

    vaccine
    International Stock News

    What if more than one company wins the coronavirus vaccine race?

    | Alex Carchidi

    The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the…

    Read more »

    CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
    International Stock News

    Coronavirus vaccine race: 7 key things you'll want to know

    | Keith Speights

    Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

    Read more »

    Patient wearing mask gets COVID vaccine injection
    International Stock News

    AstraZeneca coronavirus vaccine clinical trial paused

    | Brian Orelli, PhD

    One participant fell ill, but the connection to treatment with AZD122 is unclear.

    Read more »

    covid-19 vaccine
    International Stock News

    How to invest in coronavirus vaccine stocks

    | Keith Speights

    Just follow these three simple steps.

    Read more »

    Profile

    since

    Note